Dea

By

01-07-2026

Glass House Brands Hits NYSE as Cannabis Rescheduling Opens New Markets

Glass House Brands became the second U.S. cannabis company to list on the New York Stock Exchange this summer, a milestone that would have seemed implausible even two years ago. For Graham Farrar,

• Glass House Brands

By

25-06-2026

Federal Court, Not DEA Hearing Room, May Decide Marijuana Rescheduling's Legal Fate

The DEA's marijuana rescheduling hearing, set for June 29, has drawn intense attention from cannabis operators, investors, and compliance professionals watching for signs of what a Schedule III

• marijuana rescheduling

By

31-05-2026

Three State AGs Sue to Block Federal Marijuana Rescheduling Before It Takes Effect

Indiana Attorney General Todd Rokita has joined his counterparts in Nebraska and Louisiana in a federal lawsuit seeking to stop the U.S. Department of Justice from moving marijuana from Schedule I to

• Todd Rokita

By

03-05-2026

Cannabis Businesses Face a Calculated Risk in DEA's New Federal Registration Portal

The Drug Enforcement Administration opened an application portal on April 29 for state-licensed medical cannabis dispensaries seeking expedited Schedule III registration - a direct consequence of

• DEA

By

03-05-2026

Federal Cannabis Rescheduling Gives Hawai'i Lawmakers a Reason to Watch Washington

For the first time in decades, the federal government is moving - however cautiously - toward treating marijuana as something other than a substance with no accepted medical value. An order issued by

• Cannabis Rescheduling